Shelley Zhuang is the founder and managing partner of 11.2 Capital. He is an advisor at JupiterOne and a board member at StrikeReady and uMed (a medical record system). Was a board member of CryptoNumerics and Passage AI. He holds a Ph.D. in Computer Science from the University of California, Berkeley and a B.S. in Computer Engineering and Science from the University of Missouri.

Shelley Zhuang

Venture Capitalist | Technology Investor | AI & Deep Tech Specialist

Professional Summary

Accomplished technology investor and entrepreneur with extensive experience in venture capital, focusing on innovative tech startups in AI, computer science, and emerging technologies. Proven track record of identifying and supporting transformative companies with significant market potential.

Professional Experience

Founder and Managing Partner | Cannage Capital (June 2024 – Present)

• Establishing a strategic investment firm targeting cutting-edge technology startups
• Leveraging deep technical expertise to identify and support innovative ventures
• Focusing on emerging technologies with transformative potential

Investor | JupiterOne (2020 – Present)

• Actively involved in strategic investment decisions
• Providing guidance and support to portfolio companies
• Leveraging technical background to assess technological capabilities and market potential

Seed Investor & Board Observer | Sardine (2020 – Present)

• Conducted thorough due diligence for seed-stage investment
• Providing strategic insights and guidance to company leadership
• Supporting company’s growth and development strategies

Seed Investor | Covariant (2017 – Present)

• Identified and invested in promising AI and robotics technologies
• Supporting innovative approaches in artificial intelligence and machine learning
• Contributing to the company’s strategic development

Seed Investor & Board Member | Hinge Health (2016 – Present)

• Provided strategic guidance to digital health technology startup
• Supported company’s growth and expansion in the healthcare technology sector
• Offered technical and strategic insights to leadership team

Investment Portfolio

Savioke

• Deal Date: January 13, 2016
• Deal Type: Early Stage VC
• Industry: Electronic Equipment and Instruments
• Company Stage: Generating Revenue

Placenote

• Deal Date: April 6, 2015
• Industry: Multimedia and Design Software
• Company Stage: Generating Revenue

Ginkgo Bioworks

• Deal Date: March 18, 2015
• Industry: Biotechnology
• Company Stage: Generating Revenue/Not Profitable

Notable Labs

• Deal Date: March 1, 2015
• Industry: Drug Discovery
• Company Stage: Generating Revenue/Not Profitable

ThinAir

• Deal Date: March 1, 2015
• Industry: Network Management Software
• Company Stage: Out of Business

Caption Care

• Deal Date: January 30, 2015
• Industry: Other Healthcare Technology Systems
• Company Stage: Generating Revenue

Human Security

• Deal Date: June 24, 2014
• Industry: Network Management Software
• Company Stage: Generating Revenue

Gemshare

• Deal Date: April 3, 2014
• Industry: Other Services (B2C Non-Financial)
• Company Stage: Startup

TigerGraph

• Deal Date: December 3, 2013
• Deal Type: Seed Round
• Industry: Database Software
• Company Stage: Generating Revenue

Intematix

• Deal Date: March 13, 2012
• Deal Type: Later Stage VC
• Industry: Electrical Equipment
• Company Stage: Generating Revenue

Education

University of California, Berkeley

• Doctor of Philosophy (PhD), Computer Science

University of Missouri-Columbia

• Bachelor of Science (BS), Computer Engineering and Computer Science

Core Skills

• Venture Capital
• Technology Investment
• AI and Machine Learning
• Strategic Planning
• Technology Assessment
• Board Advisory

Investment Philosophy

Committed to backing transformative technologies with the potential to create significant impact across various sectors, with a strong focus on artificial intelligence, computer science, and innovative digital solutions.

Contact Information

• Location: United States

– LinkedIn Connections: 500+ – Professional Followers: 5,839